Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
Condition(s):Breast CancerLast Updated:January 10, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:January 10, 2024Not yet recruiting
Condition(s):Early Hormone Receptor-positive Breast CancerLast Updated:February 20, 2020Recruiting
Condition(s):Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast CancerLast Updated:May 24, 2021Enrolling by invitation
Condition(s):Hormone Receptor Positive Advanced Breast CancerLast Updated:June 23, 2020Unknown status
Condition(s):Hormone Receptor Positive Malignant Neoplasm of BreastLast Updated:January 1, 2014Unknown status
Condition(s):Ductal Infiltrating Metastatic Breast Cancer; Hormone-receptors Positive Breast CancerLast Updated:April 9, 2018Unknown status
Condition(s):Hormone Receptor-positive Metastatic Breast Cancer; HER2-negative Metastatic Breast CancerLast Updated:January 19, 2024Recruiting
Condition(s):Breast CancerLast Updated:April 3, 2012Completed
Condition(s):Early-stage Breast Cancer; Hormone Receptor Positive TumorLast Updated:November 22, 2023Recruiting
Condition(s):Hormone-receptor Positive Breast CancerLast Updated:January 12, 2018Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.